appeal

Latest stories

  • in Health care

    Amgen wins patent appeal on psoriasis drug Otzela against Zydus Pharma, Sandoz

    by

    Thousand Oaks: Amgen has announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. and Zydus Pharmaceuticals (USA), Inc. The decision affirms the permanent injunction entered by the district court prohibiting Sandoz and […] More

  • Google Wins Appeal in $20 Million Patent Lawsuit Over Chrome’s Anti-Malware Technology

    by

    Alphabet’s Google on Tuesday convinced a US appeals court to cancel three anti-malware patents at the heart of a Texas jury’s $20 million (roughly Rs. 163 crore) infringement verdict against the company. The US Court of Appeals for the Federal Circuit said that Alfonso Cioffi and Allen Rozman’s patents were invalid because they contained inventions that were not […] More

  • India Said to Plan Appeal Against WTO Panel Ruling Against ICT Import Duties in Dispute With Japan, EU

    by

    India will appeal against a ruling of the World Trade Organization’s (WTO) trade dispute settlement panel which ruled that the country’s import dues on certain information and technology products are inconsistent with the global trade norms, commerce ministry sources said. They said that the ruling will not have any adverse impact on domestic industry. The […] More

  • in Health care

    US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris

    US Supreme Court turns down Sanofi appeal to revive EpiPen suit against Viatris

    by

    Washington: The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing the market with its EpiPen auto-injector, a device used to treat severe allergic reactions. The justices turned away Sanofi’s appeal of a lower court’s ruling rejecting the […] More

  • in Health care

    Teva, Viatris win US appeal in patent fight over Parkinson’s drug

    Teva, Viatris win US appeal in patent fight over Parkinson's drug

    by

    New Delhi: Belgian biopharmaceutical company UCB on Wednesday lost its U.S. court appeal seeking to revive a patent covering its Parkinson’s disease drug Neupro, clearing an obstacle for Teva’s Actavis Laboratories UT Inc and Viatris‘ Mylan Technologies Inc to sell generic versions of the drug. The U.S. Court of Appeals for the Federal Circuit agreed […] More

  • in Health care

    Moderna fends off Arbutus appeal in COVID vaccine patent fight

    Moderna fends off Arbutus appeal in COVID vaccine patent fight

    by

    US:  U.S. appeals court handed Moderna Inc a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp patent related to the companies’ legal fight over Moderna’s blockbuster COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark Office tribunal’s ruling that the patent for Arbutus’ lipid […] More